Free Trial

Seres Therapeutics (MCRB) SEC Filings & 10K Form

Seres Therapeutics logo
$9.63 +0.13 (+1.37%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$9.52 -0.11 (-1.09%)
As of 05/2/2025 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Seres Therapeutics SEC Filings

DateFilerForm TypeView
04/14/2025
3:13 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
3:05 PM
Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
10:43 AM
Seres Therapeutics (Filer)
Form DEF 14A
03/13/2025
10:37 AM
Seres Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2025
10:24 AM
Seres Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
6:07 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:05 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:07 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:08 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:10 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:11 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 AM
Seres Therapeutics (Issuer)
Woerle Hans-Juergen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
7:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
7:05 AM
Seres Therapeutics (Issuer)
Woerle Hans-Juergen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:06 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
3:20 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:21 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
9:30 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
7:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
5:33 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:23 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:24 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:26 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:27 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2024
11:15 PM
Seres Therapeutics (Filer)
Form EFFECT
10/11/2024
3:34 PM
Seres Therapeutics (Filer)
Form 424B3
10/02/2024
7:15 AM
NESTLE SA (Reporting)
Seres Therapeutics (Issuer)
Societe des Produits Nestle S.A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
7:15 AM
NESTLE SA (Filed by)
Seres Therapeutics (Subject)
Form SC 13D/A
10/01/2024
3:46 PM
Seres Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/26/2024
3:13 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
7:30 AM
Seres Therapeutics (Filer)
Form DEFA14A
09/12/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
3:36 PM
Seres Therapeutics (Filer)
Form DEFM14A
08/19/2024
4:38 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
08/19/2024
4:42 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:45 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:48 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:29 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:36 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
5:52 AM
Seres Therapeutics (Filer)
Form PREM14A
08/15/2024
5:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
4:21 PM
Seres Therapeutics (Filer)
Form DEFA14A
08/13/2024
9:38 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:08 AM
Seres Therapeutics (Filer)
Form DEFA14A
08/07/2024
7:38 AM
Seres Therapeutics (Filer)
Form DEFA14A
08/06/2024
7:39 PM
Seres Therapeutics (Filer)
Form DEFA14A
08/06/2024
4:27 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:28 PM
Seres Therapeutics (Filer)
Form DEFA14A
08/06/2024
4:28 PM
Seres Therapeutics (Filer)
Form DEFA14A
08/06/2024
3:15 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
6:39 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:41 AM
Seres Therapeutics (Filer)
Form DEFA14A
05/17/2024
7:16 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:17 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:18 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:18 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:23 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:14 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
9:00 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
4:18 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MCRB) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners